Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.

Autor: Chou S, Erice A, Jordan MC, Vercellotti GM, Michels KR, Talarico CL, Stanat SC, Biron KK, Chou, S, Erice, A, Jordan, M C, Vercellotti, G M, Michels, K R, Talarico, C L, Stanat, S C, Biron, K K

Publikováno v: Journal of Infectious Diseases; 1995 Mar, Vol. 171 Issue 3, p576-583, 8p

In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand.

Autor: Nicolai CJ; Umoja Biopharma, Seattle, WA., Parker MH; Umoja Biopharma, Seattle, WA., Qin J; Umoja Biopharma, Seattle, WA., Tang W; Umoja Biopharma, Seattle, WA., Ulrich-Lewis JT; Umoja Biopharma, Seattle, WA., Gottschalk RJ; Umoja Biopharma, Seattle, WA., Cooper SE; Umoja Biopharma, Seattle, WA., Hernandez Lopez SA; Umoja Biopharma, Seattle, WA., Parrilla D; Umoja Biopharma, Seattle, WA., Mangio RS; Umoja Biopharma, Seattle, WA., Ericson NG; Umoja Biopharma, Seattle, WA., Brandes AH; Umoja Biopharma, Seattle, WA., Umuhoza S; Umoja Biopharma, Seattle, WA., Michels KR; Umoja Biopharma, Seattle, WA., McDonnell MM; Umoja Biopharma, Seattle, WA., Park LY; Umoja Biopharma, Seattle, WA., Shin S; Umoja Biopharma, Seattle, WA., Leung WH; Umoja Biopharma, Seattle, WA., Scharenberg AM; Umoja Biopharma, Seattle, WA., Kiem HP; Fred Hutchinson Cancer Center, Seattle, WA., Larson RP; Umoja Biopharma, Seattle, WA., Beitz LO; Umoja Biopharma, Seattle, WA., Ryu BY; Umoja Biopharma, Seattle, WA.

Publikováno v: Blood [Blood] 2024 Aug 29; Vol. 144 (9), pp. 977-987.

Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering.

Autor: Michels KR; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA kathryn.michels@umoja-biopharma.com., Sheih A; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA., Hernandez SA; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA., Brandes AH; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA., Parrilla D; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA., Irwin B; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA., Perez AM; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA., Ting HA; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA., Nicolai CJ; Discovery, Umoja Biopharma, Seattle, Washington, USA., Gervascio T; Office of Animal Care, Seattle Children's Hospital, Seattle, Washington, USA., Shin S; Vector Biology, Umoja Biopharma, Seattle, Washington, USA., Pankau MD; Process Development, Umoja Biopharma, Seattle, Washington, USA., Muhonen M; MSAT, Umoja Biopharma, Boulder, Colorado, USA., Freeman J; MSAT, Umoja Biopharma, Boulder, Colorado, USA., Gould S; MSAT, Umoja Biopharma, Boulder, Colorado, USA., Getto R; Umoja Biopharma, Seattle, Washington, USA., Larson RP; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA., Ryu BY; Discovery, Umoja Biopharma, Seattle, Washington, USA., Scharenberg AM; Umoja Biopharma, Seattle, Washington, USA., Sullivan AM; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA., Green S; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Mar; Vol. 11 (3).

The Role of Iron in the Susceptibility of Neonatal Mice to Escherichia coli K1 Sepsis.

Autor: Michels KR; Department of Pathology, Michigan Medicine, School of Public Health, University of Michigan, Ann Arbor., Lambrecht NJ; Department of Nutritional Sciences, School of Public Health, University of Michigan, Ann Arbor., Carson WF; Department of Pathology, Michigan Medicine, School of Public Health, University of Michigan, Ann Arbor., Schaller MA; Department of Pathology, Michigan Medicine, School of Public Health, University of Michigan, Ann Arbor., Lukacs NW; Department of Pathology, Michigan Medicine, School of Public Health, University of Michigan, Ann Arbor.; Mary H. Weiser Food Allergy Center, Department of Pediatrics, Michigan Medicine, Ann Arbor., Bermick JR; Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Michigan Medicine, Ann Arbor.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2019 Aug 30; Vol. 220 (7), pp. 1219-1229.

Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia.

Autor: Michels KR; Departments of Microbiology, Immunology, and Cancer Biology., Zhang Z; Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA., Bettina AM; Departments of Microbiology, Immunology, and Cancer Biology., Cagnina RE; Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA., Stefanova D; Departments of Molecular, Cellular, and Integrative Physiology, University of California, Los Angeles, California, USA., Burdick MD; Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA., Vaulont S; INSERM U1016, Cochin Institute, Descartes University, Paris, France., Nemeth E; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Ganz T; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Mehrad B; Departments of Microbiology, Immunology, and Cancer Biology.; Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.; Beirne B. Carter Center for Immunology, University of Virginia, Charlottesville, Virginia, USA.

Publikováno v: JCI insight [JCI Insight] 2017 Mar 23; Vol. 2 (6), pp. e92002. Date of Electronic Publication: 2017 Mar 23.